«QLT

Below is an extended QLT news listing. Click here to return to the QLT main Biocorporate entry.

BioNews Results for QLT:
QLT to licence its Atrigel technology to Reckitt Benckiser Pharmaceuticals Prince George Citizen: Aug 29 2008 4:26PM Matching: qlt
QLT to licence its Atrigel technology to Reckitt Benckiser Pharmaceuticals Macro World Investor: Aug 27 2008 9:02AM Matching: qlt
QLT to licence its Atrigel technology to Reckitt Benckiser Pharmaceuticals Sympatico MSN Finance: Aug 27 2008 1:10AM Matching: qlt
QLT to licence its Atrigel technology to Reckitt Benckiser Pharmaceuticals Calibre Macro World: Aug 27 2008 8:59AM Matching: qlt
QLT enters licensing pact with Reckitt Benckiser for Atrigel technology PharmaBiz: Aug 27 2008 6:46AM Matching: qlt
QLT Inc signs license agreement with Reckitt Benckiser Pharmaceuticals Inc for Atrigel technology M2: Aug 27 2008 3:41PM Matching: qlt
QLT signs licensing agreement with Reckitt Benckiser Pharmaceutical Business Review: Aug 27 2008 6:56AM Matching: qlt
QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Twin Cities Business Journal: Aug 26 2008 8:36AM Matching: qlt
QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Business Journal of Milwaukee: Aug 26 2008 6:55AM Matching: qlt
QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals San Francisco Business Times: Aug 26 2008 6:19AM Matching: qlt
QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals The Business Journal Phoenix: Aug 26 2008 6:18AM Matching: qlt
QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Atlanta Business Chronicle: Aug 26 2008 6:17AM Matching: qlt
QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals San Antonio Business Journal: Aug 26 2008 6:14AM Matching: qlt
QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Nashville Business Journal: Aug 26 2008 6:13AM Matching: qlt
QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Columbus Business First: Aug 26 2008 6:11AM Matching: qlt

«QLT

This page contained an extended QLT news listing. Click here to return to the QLT main Biocorporate entry.

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.